These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17447409)

  • 41. The history of dopamine and levodopa in the treatment of Parkinson's disease.
    Fahn S
    Mov Disord; 2008; 23 Suppl 3():S497-508. PubMed ID: 18781671
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Q&A with Dr. Yun Joong Kim.
    Kim YJ
    Mov Disord; 2018 Oct; 33(10):1564-1566. PubMed ID: 30365217
    [No Abstract]   [Full Text] [Related]  

  • 43. N-methylation of pyridines and Parkinson's disease.
    Williams AC; Pall HS; Steventon GB; Green S; Buttrum S; Molloy H; Waring RH
    Adv Neurol; 1993; 60():194-6. PubMed ID: 8420135
    [No Abstract]   [Full Text] [Related]  

  • 44. [Issue dedicated to the 70th anniversary of the birth of V.Z. Gorkin. Various biomedical aspects of amino oxidases and their inhibitors].
    Vopr Med Khim; 1997; 43(6):433-583. PubMed ID: 9537921
    [No Abstract]   [Full Text] [Related]  

  • 45. Monoamine oxidase-B inhibition in the treatment of Parkinson's disease.
    Fernandez HH; Chen JJ
    Pharmacotherapy; 2007 Dec; 27(12 Pt 2):174S-185S. PubMed ID: 18041937
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Independent discovery in biology: investigating styles of scientific research.
    Russell N
    Med Hist; 1993 Oct; 37(4):432-41. PubMed ID: 8246647
    [No Abstract]   [Full Text] [Related]  

  • 47. Mine is longer than yours: the latest boomer game.
    Kinsley M
    New Yorker; 2008 Apr; ():38-43. PubMed ID: 18494109
    [No Abstract]   [Full Text] [Related]  

  • 48. Levodopa: past, present, and future.
    Hauser RA
    Eur Neurol; 2009; 62(1):1-8. PubMed ID: 19407449
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Deep brain stimulation for Parkinson's disease and dystonia].
    Yokochi F
    Brain Nerve; 2009 Apr; 61(4):473-83. PubMed ID: 19378817
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors.
    Matos MJ; Viña D; Picciau C; Orallo F; Santana L; Uriarte E
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5053-5. PubMed ID: 19628387
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment challenges in Parkinson's disease.
    Welsh M
    Nurse Pract; 2008 Jul; 33(7):32-8. PubMed ID: 18600170
    [No Abstract]   [Full Text] [Related]  

  • 52. Interactions of imidazoline ligands with the active site of purified monoamine oxidase A.
    Jones TZ; Giurato L; Guccione S; Ramsay RR
    FEBS J; 2007 Mar; 274(6):1567-75. PubMed ID: 17480205
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of early Parkinson's disease. Part 1.
    Simuni T; Lyons KE; Pahwa R; Hauser RA; Comella C; Elmer L; Weintraub D
    Eur Neurol; 2009; 61(4):193-205. PubMed ID: 19176960
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Gifts and the caring relationship: history and perspectives...].
    Bourgeon D
    Rech Soins Infirm; 2007 Jun; (89):4-14. PubMed ID: 17674608
    [No Abstract]   [Full Text] [Related]  

  • 55. Inhibitory effect of dehydroepiandrosterone on brain monoamine oxidase activity: in vivo and in vitro studies.
    Pérez-Neri I; Montes S; Ríos C
    Life Sci; 2009 Oct; 85(17-18):652-6. PubMed ID: 19772862
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between Parkinson's disease and glucocerebrosidase mutations in Brazil.
    Spitz M; Rozenberg R; Pereira Lda V; Reis Barbosa E
    Parkinsonism Relat Disord; 2008; 14(1):58-62. PubMed ID: 17703984
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Rasagiline in Parkinson's disease].
    Linazasoro G
    Neurologia; 2008 May; 23(4):238-45. PubMed ID: 18307054
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Childhood and the loss of contact with reality: the prospects for democracy.
    Gruen A
    J Psychohist; 2009; 36(3):270-83. PubMed ID: 19235363
    [No Abstract]   [Full Text] [Related]  

  • 59. Monamine oxidase inhibitors: current and emerging agents for Parkinson disease.
    Fernandez HH; Chen JJ
    Clin Neuropharmacol; 2007; 30(3):150-68. PubMed ID: 17545750
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monoamine oxidase is not in synapse.
    Wild T
    Aust N Z J Psychiatry; 2007 Nov; 41(11):940. PubMed ID: 18074624
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.